Organ transplantation and vaccination
10.3969/j.issn.1674-7445.2022.01.002
- VernacularTitle:器官移植与疫苗接种
- Author:
Song CHEN
1
;
Weijie ZHANG
Author Information
1. Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation of Ministry of Education, Key Laboratory of Organ Transplantation of National Health Commission of China, Key Laboratory of Organ Transplantation of Chinese Academy of Medical Sciences, Wuhan 430030, China
- Publication Type:Research Article
- Keywords:
Organ transplantation;
Influenza vaccine;
Pneumococcal vaccine;
Hepatitis B vaccine;
Hepatitis A vaccine;
Rabies vaccine;
Tetanus vaccine;
Human papillomavirus vaccine;
SARS-CoV-2 vaccine
- From:
Organ Transplantation
2022;13(1):6-
- CountryChina
- Language:Chinese
-
Abstract:
Organ transplant recipients are at a high risk of infection with high hospitalization rate, critical rate and fatality, due to low immune function caused by taking immunosuppressants for a period of long time after organ transplantation. Currently, vaccination is recognized as an effective approach to prevent infection. Organ transplant recipients may be vaccinated according to individual conditions. However, the sensitivity to vaccines may decline in organ transplant recipients. The types, methods and timing of vaccination have constantly been the hot spots of clinical trials. In this article, the general principles, specific vaccines and SARS-CoV-2 vaccines of vaccination in organ transplant recipients were briefly reviewed, aiming to provide reference for the vaccination of organ transplant recipients. Moreover, current status of SARS-CoV-2 vaccination for organ transplant recipients was illustrated under the global outbreak of novel coronavirus pneumonia pandemic.
